CUTISS is a pioneering TechBio company specializing in tissue therapeutics and regenerative medicine. The company is advancing its lead product, denovoSkin™, a bio-engineered, personalized skin graft designed to enhance skin surgery outcomes. CUTISS is also developing the world's first automated manufacturing platform for personalized tissue therapy, aiming to scale production and commercialization. Additionally, CUTISS is expanding its international presence with a planned production facility in the Netherlands, in collaboration with Rode Kruis Ziekenhuis, a leading EU clinical trials center.